摘要
诺如病毒属于杯状病毒科,无包膜病毒,是全球病毒性肠胃炎的主要病原体。目前认为组织血型抗原是诺如病毒的受体。诺如病毒疫苗研究主要是重组表达病毒衣壳蛋白组装的病毒样颗粒,其与天然病毒结构相似。不同基因型的GⅡ.4的病毒样颗粒,由于在受体结合区域氨基酸的序列差异,可导致病毒与不同受体结合以及抗原性发生改变。了解病毒的结构、中和表位和抗原变异对于疫苗的研发和质控具有重要意义。
Norovirus(NoV) belongs to the family of Caliviridae without envelops. No V is the major pathogen of epidemic nonbacterial gastroenteritis in humans. No V binds to the polymorphic histoblood group antigens(HBGAs),which act as the putative cellular receptor. Researches on No V vaccine focus on the expression of the capsid protein in recombinant systems that yield assembly of virus-like particles to mimic the antigenic structure of authentic virion. Studies with virus-like particles from the GⅡ. 4 genocluster demonstrated that variation in and around the receptor-binding domain results in differential HBGA binding and altered antigenicity.
作者
姚昕
梁争论
YAO Xin;LIANG Zheng-lun(National Institutes for Food and Drug Control, Beijing 100050, China)
出处
《中国病毒病杂志》
CAS
2018年第1期72-77,共6页
Chinese Journal of Viral Diseases
关键词
诺如病毒
结构
中和表位
疫苗
Norovirus (NOV)
Structure
Neutralizing epitope
Vaccine